News

Route 92 Medical Announces Expansion to New Manufacturing Site in Salt Lake City, Utah

SAN MATEO, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated…

1 year ago

BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022

Melville, NY., Nov. 16, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (Nasdaq: BRTX), a clinical stage company…

1 year ago

Pure Extracts Receives Approval from Manitoba Liquor & Lotteries to list Pure Pulls Vapes and Pure Chews Edibles

VANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure…

1 year ago

Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™

SAN FRANCISCO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced it ranked first on the…

1 year ago

Deep Blue Med Spa Lead PA Melissa Colletti-White is One of the First Providers Nationwide to Offer JUVÉDERM® VOLUX™ XC

The First and Only HA Filler FDA-approved for Jawline Definition, Brought to Market by Allergan Aesthetics, the Makers of Botox…

1 year ago

Bicycle Health Announces Significant Milestones for 2022, Laying the Foundation for Long-term Growth

Major payor partnerships, a successful Series B, and state expansions helped the company expand access to addiction care to millions…

1 year ago

BioCorRx Provides Business Update for the Third Quarter of 2022

ANAHEIM, CA, Nov. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and…

1 year ago

Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering

Oak Ridge, TN, Nov. 15, 2022 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in…

1 year ago

BiondVax Congratulates Dirk Görlich on $1.4 million WLA Prize in Life Sciences

JERUSALEM, Nov. 15, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) (“BiondVax”), a biotechnology company focused…

1 year ago

ExCellThera announces completion of Phase 2 clinical trials for UM171-expanded cell therapy in high-risk blood cancers

MONTREAL, Nov. 15, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation,…

1 year ago